TEAR - TearLab Corporation

Other OTC - Other OTC Delayed Price. Currency in USD

TearLab Corporation

9980 Huennekens Street
Suite 100
San Diego, CA 92121
United States
858-455-6006
http://www.tearlab.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees39

Key Executives

NameTitlePayExercisedYear Born
Mr. Elias VamvakasExec. Chairman & Sec.231.51kN/A1959
Mr. Joseph S. JensenPres, CEO & Director571.93kN/A1972
Dr. Richard L. LindstromScientific Advisor & Independent Director36kN/A1948
Mr. Michael MarquezInterim Chief Financial OfficerN/AN/A1982
Dr. Benjamin Sullivan Ph.D.Chief Scientific OfficerN/AN/A1976
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab pen, a hand-held device that interfaces with the TearLab disposable; and TearLab reader, a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in San Diego, California.

Corporate Governance

TearLab Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.